We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

237 hedge funds and large institutions have $2.46B invested in Prestige Consumer Healthcare in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 110 increasing their positions, 64 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

72% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 64

12% more capital invested

Capital invested by funds: $2.19B → $2.46B (+$270M)

0% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 41

1% less funds holding

Funds holding: 239237 (-2)

1.67% less ownership

Funds ownership: 122.54%120.87% (-1.7%)

52% less call options, than puts

Call options by funds: $659K | Put options by funds: $1.37M

Holders
237
Holders Change
-2
Holders Change %
-0.84%
% of All Funds
5.43%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
41
Increased
110
Reduced
64
Closed
41
Calls
$659K
Puts
$1.37M
Net Calls
-$710K
Net Calls Change
-$398K
Name Holding Trade Value Shares
Change
Change in
Stake
Asset Management One
151
Asset Management One
Japan
$380K +$334K +9,900 New
Squarepoint
152
Squarepoint
New York
$363K -$1.12M -33,100 -78%
TRSOTSOK
153
Teachers Retirement System of the State of Kentucky
Kentucky
$360K
UFF
154
USA Financial Formulas
Michigan
$356K
Victory Capital Management
155
Victory Capital Management
Texas
$352K +$42.4K +1,257 +16%
PP
156
Paloma Partners
Connecticut
$344K +$302K +8,958 New
PA
157
Profund Advisors
Maryland
$341K -$16.8K -499 -5%
William Blair & Company
158
William Blair & Company
Illinois
$334K +$7.08K +210 +2%
XK
159
Xact Kapitalforvaltning
Sweden
$333K -$6.74K -200 -2%
MWNA
160
Marshall Wace North America
New York
$327K +$288K +8,535 New
O
161
OppenheimerFunds
New York
$326K -$22M -653,461 -99%
IG
162
ING Group
Netherlands
$312K +$2.06K +61 +0.8%
AB
163
Amalgamated Bank
New York
$300K +$5.66K +168 +2%
P
164
Pitcairn
Pennsylvania
$279K +$245K +7,278 New
HC
165
Henshaw Capital
Massachusetts
$274K +$240K +7,130 New
Nisa Investment Advisors
166
Nisa Investment Advisors
Missouri
$266K +$5.39K +160 +2%
HIMCH
167
Hartford Investment Management Co (HIMCO)
Connecticut
$263K +$231K +6,848 New
FA
168
FDx Advisors
Illinois
$253K +$2.9K +86 +1%
SAM
169
Securian Asset Management
Minnesota
$253K +$5.53K +164 +3%
DT
170
Diversified Trust
Tennessee
$253K +$20.2K +600 +10%
Polen Capital Management
171
Polen Capital Management
Florida
$253K +$222K +6,591 New
SCA
172
Secor Capital Advisors
New York
$252K -$1.52M -44,957 -87%
CGH
173
Crossmark Global Holdings
Texas
$247K +$6.41K +190 +3%
BUB
174
BBVA USA Bancshares
Texas
$240K +$211K +6,264 New
Citigroup
175
Citigroup
New York
$222K +$53.7K +1,593 +38%

PBH Hedge Fund Activity: Q2 2018 in Review

237 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2018, worth a combined $2.46B — up 12% from $2.19B a quarter earlier.

Fund positioning in PBH was balanced in Q2 2018: 41 funds opened new positions, 41 closed out, 110 added to existing stakes and 64 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $29.5M. The largest seller was Manor Road Capital Partners, cutting an estimated $53.9M.

  • 237 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2018, down from 239 in Q1 2018.
  • Funds reported $2.46B of Prestige Consumer Healthcare stock for Q2 2018, up 12% quarter-over-quarter.
  • 41 funds opened new Prestige Consumer Healthcare positions in Q2 2018 and 41 closed out, a net change of 0 holders.
  • The largest Prestige Consumer Healthcare buyer in Q2 2018 was Dimensional Fund Advisors, an estimated $29.5M added.
  • The largest Prestige Consumer Healthcare seller in Q2 2018 was Manor Road Capital Partners, an estimated $53.9M sold.

Based on aggregated 13F filings for Q2 2018.